{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:57:47Z","timestamp":1790269067745,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Disease Association","doi-asserted-by":"crossref","award":["IIRG-13-284238"],"award-info":[{"award-number":["IIRG-13-284238"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AG045757A1"],"award-info":[{"award-number":["R21 AG045757A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer\u2019s Disease Center at Boston University","award":["P30 AG13864"],"award-info":[{"award-number":["P30 AG13864"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.neuroscience.2017.05.024","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T04:49:01Z","timestamp":1495169341000},"page":"44-51","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"356","author":[{"given":"Wei Qiao","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2017.05.024_b0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0010","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/cbic.201100192","article-title":"Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Abeta40 amyloid formation and cytotoxicity","volume":"12","author":"Andreetto","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0015","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.neuroscience.2017.05.024_b0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0197-4580(00)00173-1","article-title":"Quantitative neurohistological features of frontotemporal degeneration","volume":"21","author":"Arnold","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0025","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2006-2003","article-title":"Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study","volume":"92","author":"Aronne","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0035","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0014-5793(93)80849-P","article-title":"Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5","volume":"336","author":"Baumann","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0045","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures","volume":"52","author":"Bennett","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0050","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.peptides.2004.05.021","article-title":"Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin\/intermedin family peptides in vertebrates","volume":"25","author":"Chang","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0060","doi-asserted-by":"crossref","first-page":"PL193","DOI":"10.1016\/0024-3205(95)02100-W","article-title":"Anti-inflammatory activity of amylin and CGRP in different experimental models of inflammation","volume":"57","author":"Clementi","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0065","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","article-title":"Reduced IGF-1 signaling delays age-associated proteotoxicity in mice","volume":"139","author":"Cohen","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/j.1552-4604.1996.tb04147.x","article-title":"Pharmacokinetics and pharmacodynamics of AC137 (25,28,29 tripro-amylin, human) after intravenous bolus and infusion doses in patients with insulin-dependent diabetes","volume":"36","author":"Colburn","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0075","first-page":"E694","article-title":"Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice","volume":"275","author":"Cornish","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0085","doi-asserted-by":"crossref","first-page":"e59113","DOI":"10.1371\/journal.pone.0059113","article-title":"Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic abeta peptide aggregates","volume":"8","author":"de Tullio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001015","article-title":"Cardioprotection by controlling hyperamylinemia in a \u201chumanized\u201d diabetic rat model","volume":"3","author":"Despa","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0095","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1039\/C1CS15112F","article-title":"Misfolded proteins in Alzheimer's disease and type II diabetes","volume":"41","author":"DeToma","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.neuroscience.2017.05.024_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-7634(96)00063-2","article-title":"Learning and memory in the SAMP8 mouse","volume":"22","author":"Flood","year":"1998","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0105","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.2174\/13816128113199990612","article-title":"Metabolic basis of sporadic Alzeimer's disease. role of hormones related to energy metabolism","volume":"19","author":"Folch","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0110","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2012.11.051","article-title":"Electrophysiologically identified presynaptic mechanisms underlying amylinergic modulation of area postrema neuronal excitability in rat brain slices","volume":"1494","author":"Fukuda","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)","volume":"250","author":"Gebre-Medhin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s001250051364","article-title":"Islet amyloid polypeptide in the islets of Langerhans: friend or foe?","volume":"43","author":"Gebre-Medhin","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0130","article-title":"Activity of pramlintide, rat and human amylin but not Abeta1-42 at human amylin receptors","author":"Gingell","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0135","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011585","article-title":"Alzheimer disease in 2020","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harbor perspect Med"},{"issue":"Suppl","key":"10.1016\/j.neuroscience.2017.05.024_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcb.240550006","article-title":"Molecular physiology of the islet amyloid polypeptide (IAPP)\/amylin gene in man, rat, and transgenic mice","volume":"55","author":"Hoppener","year":"1994","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0165","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: A second amyloid in Alzheimer disease?","author":"Jackson","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","article-title":"Actions of beta-amyloid protein on human neurons are expressed through the amylin receptor","volume":"178","author":"Jhamandas","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10495-011-0656-3","article-title":"Beta-Amyloid protein (Abeta) and human amylin regulation of apoptotic genes occurs through the amylin receptor","volume":"17","author":"Jhamandas","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0185","doi-asserted-by":"crossref","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"Suppl 2","key":"10.1016\/j.neuroscience.2017.05.024_b0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jnc.13632","article-title":"The amyloid cascade hypothesis: are we poised for success or failure?","volume":"139","author":"Karran","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0195","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","article-title":"Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor","volume":"32","author":"Kimura","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0200","article-title":"Pramlintide antagonizes beta amyloid (abeta)- and human amylin-induced depression of hippocampal long-term potentiation","author":"Kimura","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1053\/meta.2002.32023","article-title":"Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylin","volume":"51","author":"Kraemer","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005681","article-title":"Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation","volume":"5","author":"Kurnellas","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2003-5207","article-title":"Cdk5: one of the links between senile plaques and neurofibrillary tangles?","volume":"5","author":"Lee","year":"2003","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000147471","article-title":"Altered verbal working memory process in patients with Alzheimer's disease: an fMRI investigation","volume":"57","author":"Lim","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","article-title":"Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets","volume":"32","author":"Lukinius","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1463-1326.2012.01670.x","article-title":"The interaction of amylin with other hormones in the control of eating","volume":"15","author":"Lutz","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0235","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00294609","article-title":"Microglia in cerebellar plaques in Alzheimer's disease","volume":"80","author":"Mattiace","year":"1990","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/156720507779939850","article-title":"G protein-coupled receptor signaling complexity in neuronal tissue: implications for novel therapeutics","volume":"4","author":"Maudsley","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0250","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","article-title":"Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity","volume":"61","author":"May","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harbor perspect Med"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","article-title":"Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR","volume":"79","author":"McGeer","year":"1987","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tem.2010.05.005","article-title":"Alzheimer's disease: brain expression of a metabolic disorder?","volume":"21","author":"Merlo","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0270","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1053\/j.gastro.2011.07.034","article-title":"Changes in differential functional magnetic resonance signals in the rodent brain elicited by mixed-nutrient or protein-enriched meals","volume":"141","author":"Min","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0275","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-160800","article-title":"Amylin enhances amyloid-beta peptide brain to blood efflux across the blood-brain barrier","volume":"56","author":"Mohamed","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0280","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1523\/JNEUROSCI.15-11-07625.1995","article-title":"Islet amyloid polypeptide (amylin) is expressed in sensory neurons","volume":"15","author":"Mulder","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0285","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0016-5085(94)90118-X","article-title":"Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouse","volume":"107","author":"Mulder","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-328X(97)00178-2","article-title":"Islet amyloid polypeptide and calcitonin gene-related peptide expression are upregulated in lumbar dorsal root ganglia after unilateral adjuvant-induced inflammation in the rat paw","volume":"50","author":"Mulder","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-328X(99)00335-6","article-title":"Localization of calcitonin receptor mRNA in the mouse brain: coexistence with serotonin transporter mRNA","volume":"76","author":"Nakamoto","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0300","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1210\/mend-3-11-1775","article-title":"Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history","volume":"3","author":"Nishi","year":"1989","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0305","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-2007-978867","article-title":"Plasma amylin immunoreactivity and insulin resistance in insulin resistant relatives of patients with non-insulin-dependent diabetes mellitus","volume":"30","author":"Nyholm","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0310","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.peptides.2007.06.011","article-title":"Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat","volume":"28","author":"Olsson","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","article-title":"On the relation of chronic interstitial pancreatitis to the islands of langerhans and to diabetes melutus","volume":"5","author":"Opie","year":"1901","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004010051002","article-title":"Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue","volume":"97","author":"Overmyer","year":"1999","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0325","article-title":"Effect of active Abeta immunotherapy on neurons in human Alzheimer's disease","author":"Paquet","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0330","doi-asserted-by":"crossref","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","article-title":"Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells","volume":"272","author":"Paresce","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0335","doi-asserted-by":"crossref","first-page":"R340","DOI":"10.1152\/ajpregu.00380.2011","article-title":"Involvement of the extracellular signal-regulated kinase 1\/2 signaling pathway in amylin's eating inhibitory effect","volume":"302","author":"Potes","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0340","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.physbeh.2010.03.001","article-title":"Brainstem mechanisms of amylin-induced anorexia","volume":"100","author":"Potes","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0345","doi-asserted-by":"crossref","first-page":"e88063","DOI":"10.1371\/journal.pone.0088063","article-title":"Association between Amylin and Amyloid-beta Peptides in Plasma in the Context of Apolipoprotein E4 Allele","volume":"9","author":"Qiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0350","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0355","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fnagi.2014.00186","article-title":"Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?","volume":"6","author":"Qiu","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0360","doi-asserted-by":"crossref","first-page":"20797","DOI":"10.1074\/jbc.M111.234674","article-title":"Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation","volume":"286","author":"Reifert","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0365","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","article-title":"Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease","volume":"9","author":"Rogers","year":"1988","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0370","article-title":"Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease","author":"Roostaei","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0375","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MED.0b013e32835b896f","article-title":"Amylin and the regulation of appetite and adiposity: recent advances in receptor signaling, neurobiology and pharmacology GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities","volume":"20","author":"Roth","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02899034","article-title":"Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study","volume":"51","author":"Rozemuller","year":"1986","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0385","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study","volume":"75","author":"Schrijvers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0390","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/anie.201105877","article-title":"Cross-amyloid interaction of Abeta and IAPP at lipid membranes","volume":"51","author":"Seeliger","year":"2012","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0395","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ana.24001","article-title":"The therapeutics of Alzheimer's disease: where we stand and where we are heading","volume":"74","author":"Selkoe","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bpc.2010.01.006","article-title":"Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin","volume":"150","author":"Sellin","year":"2010","journal-title":"Biophys Chem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0405","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.drudis.2008.12.009","article-title":"Modulating receptor function through RAMPs: can they represent drug targets in themselves?","volume":"14","author":"Sexton","year":"2009","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0410","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism","volume":"443","author":"Shen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0415","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2017.05.024_b0420","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1006\/jmbi.1997.1348","article-title":"Common core structure of amyloid fibrils by synchrotron X-ray diffraction","volume":"273","author":"Sunde","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn2977","article-title":"The role of G protein-coupled receptors in the pathology of Alzheimer's disease","volume":"12","author":"Thathiah","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0430","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1210\/en.2010-0590","article-title":"Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats","volume":"151","author":"Trevaskis","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0435","doi-asserted-by":"crossref","first-page":"e73080","DOI":"10.1371\/journal.pone.0073080","article-title":"Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells","volume":"8","author":"Trikha","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0440","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","article-title":"P35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0445","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1242\/dev.119.4.1029","article-title":"Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system","volume":"119","author":"Tsai","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0450","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-2007-978937","article-title":"Plasma amylin concentrations in fasted and fed rats quantified by a monoclonal immunoenzymometric assay","volume":"30","author":"Vine","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0455","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.3390\/nu7095341","article-title":"Shared neuropathological characteristics of obesity, type 2 diabetes and Alzheimer's disease: impacts on cognitive decline","volume":"7","author":"Walker","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0460","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JAD-160677","article-title":"Amylin treatment reduces neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of an Alzheimer's disease mouse model","volume":"56","author":"Wang","year":"2017","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0465","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0470","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0475","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1615\/CritRevNeurobiol.v11.i2-3.40","article-title":"Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily","volume":"11","author":"Wimalawansa","year":"1997","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0480","article-title":"Molecular characterization of the hetero-assembly of beta-amyloid peptide with islet amyloid polypeptide","author":"Yan","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0485","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/anie.200604056","article-title":"IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes","volume":"46","author":"Yan","year":"2007","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0490","doi-asserted-by":"crossref","first-page":"10378","DOI":"10.1002\/anie.201302840","article-title":"Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Abeta40","volume":"52","author":"Yan","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0495","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1471-4159.2000.0741017.x","article-title":"Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia","volume":"74","author":"Yates","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0500","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1054-3589(05)52017-9","article-title":"Central nervous system and other effects","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0505","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1054-3589(05)52003-9","article-title":"Receptor pharmacology","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0510","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuropharm.2016.07.008","article-title":"Multiple target of hAmylin on rat primary hippocampal neurons","volume":"113","author":"Zhang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0515","first-page":"33","article-title":"An amylin analog used as a challenge test for Alzheimer\u2019s disease","volume":"3","author":"Zhu","year":"2017","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0520","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2017.03.030","article-title":"Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease","author":"Zhu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2017.05.024_b0530","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer's disease and after active amyloid-beta42 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217303494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217303494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T18:36:28Z","timestamp":1659033388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452217303494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":106,"alternative-id":["S0306452217303494"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2017.05.024","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}